Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BolA family member 3 (BOLA3) is a mitochondrial protein essential for the assembly and insertion of iron-sulfur (Fe-S) clusters into specific mitochondrial enzymes, including those within the respiratory chain and lipoate-containing 2-oxoacid dehydrogenases[1][2][3][4][5][6]. It supports the maturation of mitochondrial proteins important for cellular energy production and metabolism, and is especially important in tissues with high mitochondrial activity such as brown/beige adipose tissue, where it regulates thermogenesis via mitochondrial homeostasis and adrenergic signaling[2][3]. Mutations in BOLA3 result in multiple mitochondrial dysfunctions syndrome type 2, a severe disorder manifesting with defects in respiratory chain complexes, dehydrogenases, glycine cleavage system, leading to metabolic failure and early lethality[1][4][6]. BOLA3 is not classified as a classical drug target (e.g., receptor, enzyme), and there are currently no drug interactions or clinically used biomarkers described for this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BolA family member 3 (BOLA3).